Hemodialysis-associated protein catabolism with and without glucose in the dialysis fluid  by Gutierrez, Alberto et al.
Kidney International, Vol. 46 (1994), pp. 814—822
Hemodialysis-associated protein catabolism with and without
glucose in the dialysis fluid
ALBERTO GUTIERREZ, JONAS BERGSTROM, and A. ALVESTRAND
The Department of Renal Medicine, Huddinge University Hospital, Karolinska Institute, Stockholm, Sweden
Hemodialysis-associated protein catabolism with and without glucose
in the dialysis fluid. The effects of hemodialysis on protein and energy
metabolism were studied in eight hemodialysis patients. The leg exchange
of amino acids (AA) was measured during hemodialysis using a dialysis
fluid with 10 mmollliter glucose (GD) or without glucose (GFD). Arterial
AA concentrations decreased by about 30% in GD and GFD. During
dialysis, similar increases in the efflux of AA from leg tissues (mainly
muscle) were observed in GD and GFD (basal 105 104, vs. 71 62
nmol/min/100 g tissue; dialysis 295 46 vs. 289 60 nmol/min/100 g
tissue). The efflux of AA remained largely unchanged at one hour after the
end of GD and GFD. Losses of AA to the dialysate were similar during
GD (8.3 0.9 g) and GFD (7.9 0.4; NS). GFD resulted in a loss of 26
g of glucose whereas 30 of glucose was absorbed during GD. The amount
of urea removed by dialysis and the post-dialysis increase in plasma urea
were similar in GD and GFD. In conclusion, the addition of glucose to the
dialysis fluid may help the energy balance, but it does not appear to reduce
the negative effects of hemodialysis on protein metabolism.
Wasting and malnutrition are common in chronic hemodialysis
patients [1—3]. Reduced intakes and increased requirements of
nutrients due to the uremic state contribute to the development of
malnutrition in these patients [4]. In addition, hemodialysis
treatment has been reported to be a catabolic event manifested by
increased urea appearance during dialysis [5, 6] and a negative
nitrogen balance on "dialysis days" regardless of protein intake
[7]. The presence of endotoxins in the dialysis fluid may elicit an
inflammatory response with the release of cytokines (IL-i, TNF)
which are known to stimulate proteolysis [8]. Blood Contact with
bioincompatible dialysis membranes has been reported to accel-
erate muscle protein breakdown in normal subjects [9, 10].
The loss of free and bound amino acids during dialysis, which
amounts to about 6—13 g per dialysis, may constitute an additional
catabolic factor [11—13]. Another potential cause of net protein
catabolism may be the loss of 25 to 30 g glucose during hemodi-
alysis with glucose-free dialysis fluid [6, 14], which elicits an
increased splancnic glucose production to sustain blood glucose
levels. During and after a meal, glucose may be generated from
carbohydrates in the food and from glycogenolysis in the liver.
However, in starvation, increased mobilization of amino acids
from muscle stores is required in order to maintain glucose
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homeostasis (gluconeogenesis). Decreases in gluconeogenetic
precursors, which cannot be accounted for by losses in the
dialysate, such as of pyruvate and lactate [14] or alanine [15], have
been taken as evidence of enhanced gluconeogenesis due to loss
of glucose during dialysis [16]. Accordingly, one would expect that
hemodialysis with glucose-containing dialysis fluid might have a
positive effect on protein metabolism by decreasing gluconeogen-
esis and perhaps also by stimulating the secretion of insulin, which
is known to induce a decrease in proteolysis [17].
Only a few studies have addressed the problem of whether
hemodialysis with glucose in the dialysis fluid may result in
reduced protein catabolism, compared to dialysis with glucose-
free dialysis. Farrell and co-workers [5, 6] studied urea appear-
ance repeatedly during hemodialyses with either glucose-free
dialysis fluid or dialysis fluid containing glucose (11 mmollliter or
26 mmollliter) and found no difference whether or not the dialysis
fluid contained glucose. Kopple et a! [11] observed in patients
studied after an overnight fast that the addition of glucose (25
mmollliter) to the dialysis fluid resulted in a decreased dialytic loss
of amino acids when compared to glucose-free dialysis, and they
concluded that glucose in the dialysis fluid has a protein-sparing
effect. However, no more than four dialysis sessions with glucose
and three sessions with glucose were studied. Hence, the results
have to be considered as preliminary. More recently, Ono, Sasaki
and Waki [13] reported that in non-fasting patients the dialytic
loss of amino acids was not significantly different with or without
glucose in the dialysis fluid.
In patients who are in good clinical condition the moderate
losses of glucose and amino acids during dialysis should easily be
compensated for by adequate nutritional intake and especially by
ingestion of food during dialysis. However, many dialysis patients
suffer from anorexia, gastrointestinal or other disturbances, which
may grossly impair or preclude oral intake of nutrients before and
during dialysis. It is therefore important to know if it is worthwhile
to use glucose-containing dialysis fluid in order to reduce protein
catabolism and amino acid loss during hemodialysis in fasting
patients, especially since earlier results are scanty and of doubtful
significance.
To elucidate this question we have investigated the metabolic
effects of hemodialysis with or without glucose in the dialysis fluid
by measuring the exchange of amino acids across the leg, the
dialytic losses of urea and amino acids and the dialytic loss or
uptake of glucose. The studies were made in chronic hemodialysis
patients after an overnight fast.
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Methods
Subjects
Eight male chronic uremic patients participated in the study.
They ranged in age from 48 to 77 years (median 59 years) and had
undergone maintenance hemodialysis for a median of 22.5
months (range 8 to 57 months). All patients were in good general
and nutritional health (body mass index 22.5 0.9, hematocrit
28 0.7%, protein catabolic rate >1.0 g protein/kg body
weight*day). None of them had a residual renal urea clearance
>0.1 mI/mm. The causes of renal failure included chronic glomer-
ulonephritis in five patients, polycystic kidney disease in one and
amyloidosis in two patients. All were dialyzed with a glucose-free
dialysis fluid, thrice weekly for three to four hours, blood flow 250
to 400 ml/min and dialysate flow 500 mI/mm (Kt/V >1.0). The
Baxter CA® 170 g dialyzer was used in six patients and the
Gambro GFSPlus 20 dialyzer in two patients. The nature, purpose
and potential risks of the study were carefully explained to all of
them before they consented to participate. The study protocol was
approved by the Ethics Committee of the Karolinska Institute at
Huddinge Hospital.
Procedure
1-lemodialysis. Each patient was studied on two occasions with a
one-week interval, in random order, using dialysis fluid with (GD)
or without (GFD) glucose. The fluid contained sodium 142
mmol/liter, calcium 1.5 mmol/liter, magnesium 0.5 mmol/liter,
bicarbonate 32 mmol/liter, potassium 1 or 2 mmol/liter, according
to the patients needs, and either glucose 10 mmol/liter or no
glucose. Apart from the presence or absence of glucose in the
dialysis fluid, the procedure was identical on both occasions and in
accordance with the patients previous hemodialyses. An arterio-
venous fistula or Gortex graft was used as the blood access for
hemodialysis. After a 12-hour overnight fast, polyethylene cathe-
ters for blood sampling were inserted into a femoral artery and
ipsilateral femoral vein. After the insertion of the femoral cathe-
ters, the patients rested for 60 minutes before the hemodialysis
was started.
Sampling and measurements. Plasma glucagon, plasma insulin,
plasma glucose and serum urea were determined in samples from
arterial blood, whereas samples for amino acid determinations
were taken simultaneously from arterial and venous catheters.
Samples for glucagon and insulin were taken pre-dialysis (basal),
at the end of dialysis (end) and 60 minutes after dialysis (60 mm
post-dialysis). Samples for plasma amino acids and plasma glucose
were taken in the basal state, at 60 minutes, 120 minutes, 180
minutes, at the end of dialysis (180 mm, N = 1; 210 mm, N = 5;
240 mm, N = 2) and at 60 minutes post-dialysis. Serum urea was
determined at the start, at the end of dialysis and at 10, 20, 30, 40
and 60 minutes post-dialysis. Leg blood flow was measured by
venous occlusion plethysmography [18], immediately after blood
sampling for determination of amino acids at each time-point.
Dialysate samples were taken from a sampling port in the
dialysate outflow tube. Two ml samples were withdrawn every 15
minutes throughout the dialysis. These samples were placed
together in a jug packed with ice, Following dialysis and after
appropriate mixing, a 10 ml sample was taken to determine the
glucose, urea and the various amino acid concentrations, The
uptake of glucose from the dialysis fluid or the loss of glucose into
the dialysate was calculated as the difference between the initial
Table 1. Plasma flow in a group of eight chronic dialysis patients,
before (basal), during hemodialysis (60, 120 and 180 mm), at the end of
dialysis (end), and one hour after the end of hemodialysis (60 mm post-
dialysis), using a dialysis fluid with (GD) or without glucose (GFD)
GD GFD
Basal 1.45 0.3 1.30 0,2
60 mm 1.56 0,4 1.27 0.2
120 mm 1.63 0.3 1.43 0.2
180 mm 1.25 0.3 1.37 0.2
End of dialysis 1.21 0.2 1.30 0.2
60 mm post-dialysis 1.23 0.2 1.22 0.2
Results arc expressed as ml/min/100 g tissue (mean 5EM).
concentration of glucose in the dialysis fluid and the total amount
of glucose contained in the circulated dialysate during the hemo-
dialysis. The total amount of dialysate circulated through the
dialyzer during dialysis was obtained by examining the display on
channel two (circulated dialysate + ultrafiltration) in the Filtra-
tion Control Monitor (FCM; Gambro, Lund, Sweden). The leg
plasma flow (Op) was derived from the subjects blood flow (Qb)
and hematocrit (Hct), using the formula Op = Ob x (100 —
Hct)/100. The leg amino acid balance was calculated by multiply-
ing the arterio-femoral venous concentration difference for indi-
vidual amino acids by the leg plasma flow.
Analytical methods
Blood samples for amino acid analysis were kept on ice. After
precipitation with 4% SSA, the plasma samples were centrifuged
at + 8°C and the supernatants were kept frozen (—70°C)until they
were analyzed. The plasma concentrations of individual amino
acids were measured by the HPLC method, using a pre-column
derivatization procedure with orthophthaladehyde [19]. Analyses
of amino acids in dialysate were performed in non-deproteinized
samples, in accordance with previous descriptions [11] of the same
HPLC method. Glucose and urea concentrations in plasma and
dialysate were measured using an IL 919 system (Instrumentation
Laboratory, Milan, Italy). The concentrations of insulin (normal
value <19 gU/mI) and glucagon (normal value <232 pg/ml) in
plasma were analyzed, as previously described [20, 21].
Presentation of data
If not stated otherwise, all data are presented as means 5EM.
The Student's t-test for paired data was used to evaluate the
results. Analysis of variance (ANOVA) for repeated measure-
ments followed by the paired t-test, corrected for multiple com-
parisons, was used. Differences between means of samples with
skewed distribution [22] were assessed with the Wilcoxon
matched-paired signed-rank test. Correlations were tested by
linear regression analysis. A two-tailed P value < 0.05 was
considered statistically significant.
Results
Leg plasma flow
The values of plasma flow in the leg determined before, during
and 60 minutes after hemodialysis are presented in Table 1. The
plasma flow remained constant during and after hemodialysis and
no difference was observed between dialysis with or without
glucose.
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Table 2. Arterial amino acid concentrations (mol/liter) before (basal), at the end (end) and 60 mm after the end (60 mm post-dialysis) of
hemodialysis, using a dialysis fluid with (GD) or without glucose (GFD)
Dialysis
fluid
GD
GFD
GD
GFD
GD
GFD
GD
GFD
GD
GFD
GD
GFD
GD
GFD
GD
GFD
GD
GFD
GD
GFD
GD
GFD
GD
GFD
GD
GFD
GD
GFD
GD
GFD
GD
GFD
GD
GFD
GD
GFD
GD
GFD
Basal
84.68 5.70
88.80 8.20
64.26 5.50
59.86 4.10
91.78 7.10
90.78 7.50
171.50 19.70
165.63 12.70
27.70 2.40
22.70 2.90
68.16 5.80
62.98 7.10
141.63 17.20
128.08 15.40
39.61 3.30
39.85 3.20
181.63 13.30
182.38 13.40
244.96 37.50
276.25 35.10
105.19 5.30
101.95 6.50
53.43 3.70
52.04 4.30
740.93 53.10
696.88 40.70
294.84 33.00
310.75 33.70
71.05 6.90
67.89 3.40
88.54 4.30
89.70 7.90
40.69 2.20
38.74 3.50
18.21 1.30
17.76 1.90
2528.76 125.80
2493.00 142.50
End
51.59 2.50a
60.10 6.40a
49.06 3.10
64.96 5.90
86.74 4.10
112.84 9.20
117.13 11.90
131.66 10.80
23.19 2.80a
20.60 4.80
52.30 2.90a
54.38 4.90
83.20 7.1o
85.90 8.50
28.50 1.80
33.03 4.20
114.25 4.70a
143.35 12.90a
148.00 15.30
163.88 16.20a
63.85 2.30a
70.04 6.30a
37.24 1.96a
36.88 3.90'
541.00 33.70
555.50 35.90a
212.50 25.40a
226.63 24.50k'
46.71
43.01 2.80a
59.19 5.20
67.49 7.90a
23.66 2.30a
24.16 1.90k
19.24 1.20
18.83 2.10
1757.34 64.90a
1913.18 140.60a
60 Mm
post-dialysis
61.78 290b
64.58 600b
57.94 3.50'
65.48 3.20
100.66 527b
120.50 6.90
145.88 1830b
146.75 1220b
23.75 2.10
21.76 4.50
57.44 3.10
57.99 4.10
100.03 960b
93.50 8.10
32.99 140b
35.14 3.80
134.25 690b
155.00 10.10
187.75 2890b
190.63 2110b
74.20 4.40
79.05 7•10b
45.01 260b
41.20 3.60
681.38 5420b
625.75 4190b
267.50 4020b
266.00 3130b
47.56 4.20
48.36 280b
74.73 4•40b
74.93 8.70
30.24 3•60b
30.13 190b
20.64 1.20
22.30 220b
2143.70 11970b
2139.03 14550b
Plasma amino acid concentrations
The arterial concentrations of the amino acids are given in
Table 2. In the basal state, plasma levels of amino acids did not
differ between dialysis with or without glucose. Hemodialysis was
associated with significant decreases in all measured amino acids,
except LEU and TRP in dialysis with glucose and ILE, LEU,
MET, PHE, TYR and TRP in dialysis without glucose. The
decline in the plasma amino acid concentrations, calculated as the
sum of the concentrations of the measured amino acids, was
highly significant (P < 0.001) and quantitatively similar (approx-
imately 30%) during dialysis with either solution.
After the dialysis the plasma arterial concentrations of most
amino acids rose significantly. However, after one hour the
plasma concentrations of the amino acids were the same in the
GD and GFD groups.
Amino acid exchange in the leg
The duration of hemodialysis (HD) in each patient corre-
sponded to the average duration of the leg exchange when the
three or four blood samples were taken at 60 minutes, 120
minutes, 180 minutes, and at the end of the dialysis (180 mm, N =
1; 210 mm, N = 5; 240 mm, N = 2; Table 3).
Compared to basal values, the efflux of most amino acids
increased significantly during hemodialysis. In the case of the E of
the amino acids measured, an increase in the release from 105
104 in the basal state to 295 46 nmol/min/100 g tissue during
hemodialysis was observed in GD as compared with an increase
from 71 62 to 289 60 nmol/min/100 g tissue in GFD. The
magnitude of the increases did not differ significantly between the
two types of dialysis. One hour after the end of either form of
hemodialysis, the leg efflux of amino acids had decreased slightly,
although not significantly, as compared to the end of dialysis.
The presence of glucose in the dialysis fluid did not influence
this response since, during as well as after dialysis, the release of
amino acids by leg muscle tissues was the same in the GD and
GFD groups.
The total release of individual amino acids in each patient
during hemodialysis may be calculated as the total area under the
Amino
acid
HIS
ILE
LEU
LYS
MET
PHE
THR
TYR
VAL
ALA
ARG
ASN
GLN
GLY
ORN
SER
TAU
TRP
£AA basal
Data are mean SEM.
a p  0.05 compared to basal values before starting the hemodialysis
'P 0.05 compared to values at the end of hemodialysis
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Table 3. Leg exchange of amino acids (nmol/min/100 g tissue) before (basal), during dialysis and 60 mm after (60 mm post-dialysis) of
hemodiatysis, using a dialysis fluid with (GD) or without glucose (GFD)
Basal During HD
60 Mm
post-dialysis
HIS GD
GFD
—0.56 3.30
1.97 2.20
—7.19 1.55c
—3.22 4.57
—7.78 4.31
—5.48 2.40
ILE GD
GFD
—0.79 2.60
—1.07 1.40
—5.92 1.55c
—3.31 2.05
—5.31 3.10
—8.74 2.90
LEU GD
GFD
0.36 3.95
—0.62 2.90
—9.85 2.66'
—8.22 3.00
—10.61 6.30
—12.28 5.10
LYS GD
GFD
—2.61 6.90
—3.15 4.10
—18.99 357C
—18.10 3.48"
—13.81 7.70
—13.93 6.40
MET GD
GFD
—1.46 1.30
—1.64 0.80
—3.61 0.75
—4.80 1.29c
—9.20 4.70
—3.19 0.90
PHE GD
GFD
0.54 2.70
—0.60 2.60
—8.32 1.60c
—6.66 165b
—1.68 7.20
—4.99 2.40
THR GD
GFD
—4.41 5.00
—4.66 2.60
—15.98 2.11"
—16.30 2.59"
—13.22 5.10
—11.17 3.80
TYR GD
GFD
—2.09 1.50
—0.20 1.10
—5.42 0.38a
—5.86 1.38k'
—5.73 2.50
—3.67 1.40
VAL GD
GFD
4.39 7.50
4.13 5.50
—14.17 4.46"
—10.99 3.84a
—9.09 8.10
—10.29 6.90
ALA GD
GFD
—68.45 24.30
—52.79 9.70
—68.02 8.53
—76.27 13.30
—62.73 15.60
—65.54 15.10
ARG GD
GFD
—8.47 4.20
—1.56 2.90
—13.48 2.01
—14.10 3.03"
—17.63 6.50
—11.42 3.50
ASN GD
GFD
—3.77 2.20
—1.76 1.30
—7.05 1.18"
—7.98 1.75"
—7.18 2.90
—6.37 2.10
GLN GD
GFD
—37.33 30.90
—22.00 18.70
—84.69 15.6P
—80.54 20.44a
—38.56 16.80
—62.21 20.00
GLY GD
GFD
—4.63 11.40
—7.80 7.60
—28.41 6.28"
—31.02 6.81"
—14.48 15.50
—19.48 9.50
ORN GD
GFD
6.32 4.10
3.23 2.70
—2.79 1.61
—1.62 1.43
—3.34 3.20
—0.97 3.20
SER GD
GFD
7.58 2.70
8.86 4.10
—1.50 3.21
—0.18 1.79"
1.16 4.10
—2.00 4.20
TAU GD
GFD
9.32 2.90
8.31 3.20
0.41 1.27"
—0.47 0.92"
4.38 2.20
3.56 3.10
TRP GD
GFD
0.24 0.80
0.53 1.30
—0.46 0.65
0.71 1.16
—8.68 5.60
0.04 1.10
AA GD
GFD
—105.83 104.30
—70.81 62.30
—295.44 45.66"
—288.94 59.71"
—223.49 100.40
—237.52 76.70
Data are mean SEM.
average value of the four time-periods during dialysis, calculated for each subject separately
b P 0.05 compared to basal value
p  0.025 compared to basal value
curve (AUC; nmol/100 g tissue/hemodialysis) of amino acid
release in the leg, whereas the incremental area (nmol/100 g
tissue/hemodialysis) equals the total AUC — the release at the
start of hemodialysis X the duration of hemodialysis (mm).
Significant positive incremental areas were observed in the GD
and GFD groups. In the GD groups significant incremental areas
were observed for all amino acids, except MET, ALA, ASN,
ORN, SER and TRP, whereas in the GFD group the incremental
areas of HIS, ILE, LEU, ORN and TRP did not reach statistical
significance. The release of individual amino acids or the sum of
all measured amino acids was the same with both types of
hemodialysis.
Amino acids in dialysis fluid
Data on free amino acid losses to the dialysate during hemo-
dialysis are presented in Table 4. Similar amounts of amino acids
were lost to the dialysate in the GD (8.3 0.9 g) and GFD
(7.9 0.4 g; NS) groups. In both groups the quantity of individual
amino acids contained in the dialysate showed a high correlation
to the average plasma arterial concentration of the individual
amino acids during the hemodialysis (r = 0.975). Similarly, the
total amount of each amino acid in the dialysate was highly
correlated to the degree of change in the release of these amino
acids by the leg tissues ( end-basal) in both the GD (r = 0.93,
P < 0.001) and in the GFD (r = 0.90, P < 0.001) groups (Fig. 1).
Hormones
The basal plasma concentrations of insulin and glucagon were
the same in the GD and GFD groups (Fig. 2). During GD, the
plasma concentration of insulin rose significantly, whereas during
GFD, the concentration fell significantly. During the post-dialysis
period, the levels returned to the initial values in both groups. In
contrast the plasma glucagon concentrations showed no signifi-
cant changes during or after hemodialysis.
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Table 4. Total loss of amino acids (mol) to the dialysate during
hemodialysis using dialysis fluid with (GD) or without glucose (GFD)
GD GFD
HIS 1867 193 1913 121
ILE 2046 304 2066 289
LEU 2788 286 2913 220
LYS 3279 724 2700 185
MET 859 75 643 55
PHE 1680 221 1571 182
TUR 2964 472 2574 268
TYR 861±53 911±59
VAL 4570 471 4887 423
ALA 5701 663 5525 458
ARG 1965 179 1888 96
ASN 1184 152 1160 88
GLN 17529 1438 16228 634
GLY 8093 1195 7656 824
ORN 3396 1403 2924 489
SER 2510 148 2502 239
TAU 665 74 640 40
CIT 2685 401 2653 246
IAA 65113 7319 62116 3392
Data are mean SEM.
Glucose
As seen in Figure 3, when glucose was present in the dialysis
fluid, the plasma glucose gradually rose until the end of dialysis
and then fell to the pre-dialysis levels. In contrast, when no
glucose was present in the dialysis fluid, the plasma glucose
concentration steadily fell during hemodialysis, but it then in-
creased significantly during the post-dialysis period. The changes
in the plasma glucose levels during dialysis showed a correlation
to the changes in the plasma insulin levels (r = 0.69, P = 0.006).
The former changes were highly correlated to the amount of
glucose absorbed from the dialysis fluid or lost to the dialysate
(r = 0.83, P < 0.001). The presence of glucose in the dialysis fluid
resulted in an uptake of 29.4 7 g during hemodialysis whereas
the absence of glucose in the fluid resulted in a total loss of
glucose amounting to 25.6 3.4 g (Fig. 4).
Urea
With both dialysis regimens the concentrations of the pre-
dialysis plasma urea and the magnitude of the decline in the
concentrations of plasma urea during dialysis were virtually
identical (Fig. 5). Likewise, the total amounts of urea in the
dialysate were similar (GD 608 59 mmol and GFD 529 62
mmol) (Fig, 6).
During the 60 minute post-dialysis period, the plasma urea level
rose rapidly, averaging 1.63 0.23 mmollliter in the GD group
and 1.77 0.17 mmollliter in the GFD group (not significant).
Discussion
The results of this study confirm that hemodialysis using a
glucose-free dialysis fluid is associated with losses of about 8 g of
free amino acids into the dialysate and marked decreases in the
arterial concentrations of amino acids. In addition, release of
amino acids in the leg, increased about threefold during dialysis of
glucose-free fluids. The dialytic loss of amino acids, the release of
amino acids from the leg, and the loss of urea, were not
significantly different with or without glucose in the dialysis fluid.
Regardless of the type of dialysis fluid, the amount of individual
amino acids lost to the dialysate showed a high correlation with
the changes in the respective plasma amino acid concentrations,
indicating that the loss of amino acids into the dialysate contrib-
uted to the reduction in the plasma arterial concentrations. In
agreement with previous observations 112], the amount of free
amino acids lost to the dialysate exceeds the amount normally
contained in the entire extracellular compartment. Thus, a sub-
stantial amount of amino acids must have been released from the
tissues to compensate for the gradual decline in the extracellular
amino acid levels. In both the GFD and GD groups the quantities
of individual amino acids in the dialysate were highly correlated to
the changes in balance of amino acids in the leg tissue, suggesting
that muscle amino acids were released down an intracellullar-
extracellular concentration gradient. However, it cannot be de-
duced from the present data whether net muscle protein break-
down is involved in this reaction, as suggested [12].
It may be inferred that the amino acid exchange in the leg
tissues was not assessed during steady-state conditions, as evi-
denced by continuous loss of arterial amino acids to the dialysate
during hemodialysis with and without glucose. In the present
study, calculations of leg exchanges were based on plasma amino
acid determinations. However, circulating erythrocytes have been
reported to actively participate in amino acid transport [23].
Accordingly, it has been proposed that in the assessment of the
true rate of amino acid efflux from peripheral tissues, whole blood
amino acid determinations, rather than plasma, should be used
[24]. This is especially applicable in conditions where a steady
state cannot be obtained [25]. Quantitative estimates should
therefore be interpreted with some caution. Assuming that the
changes in plasma arteriovenous differences are at least as large as
those observed in whole blood, as reported [23], it seems unlikely
that the efflux of amino acids from leg tissues has been overesti-
mated. If we further assume that the release of amino acids in the
leg reflects that of the total body muscle mass (40% of body wt),
the increases observed in the release of amino acids in muscle
cannot fully account for the total amount of amino acids lost into
dialysate. This suggests that amino acids derived from non-muscle
tissues may have partly made up for the falling concentrations of
circulating amino acid concentrations.
The release of most amino acids in the leg tissue increased
significantly during dialysis of fluids that did not contain glucose.
Similarly, during glucose dialysis, comparable increases in the
release of amino acids in the leg were observed, which was
unexpected since the glucose and insulin concentrations in the
plasma rose significantly. Glucose and insulin are known to favor
the uptake of amino acids by muscle cells in normal [26] and
uremic subjects [27], and insulin reduces proteolysis in skeletal
muscle [17].
It has been shown that modest increases of about 10 jLU/ml in
plasma insulin are needed to promote the cellular uptake of
amino acids [28]. The increases observed in the levels of plasma
insulin during GD may therefore have been too small (5 to 7
U/ml) to counterbalance the dialysis-induced tissue release of
amino acids. In addition, hypoaminoacidemia may have blunted
the antiproteolytic action of insulin [29, 30]. The glucose in the
dialysis fluid resulted in similar changes in the plasma urea levels
and in the amount of urea removed during hemodialysis, com-
pared to the dialysis of fluids not containing glucose. Moreover,
during the post-dialytic period the rate of increase in the plasma
urea level was also comparable in both dialysis modalities.
(I)
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The results of the present study indicate that the presence of
glucose in dialysis fluid in a concentration of 10 mmol/liter does
not have a nitrogen-sparing effect and does not reduce dialytic
amino acid losses in fasting hemodialysis patients in spite of
preventing glucose loss and stimulating insulin secretion. This is in
contrast to the few observations earlier reported by Kopple et a!
[11] suggesting that glucose in the dialysis fluid has an amino
acid-sparing effect in fasting patients. In that study the glucose
concentration was much higher (25 mmol/liter) and might have
induced a more marked stimulation of insulin secretion than in
the present study.
Our results are in keeping with previous studies showing that
addition of glucose to the dialysis fluid does not reduce amino acid
losses or decrease protein catabolism. However, the results are
not directly comparable since in the study of Ono, Sasaki and
Waki [13] the patients were not fasting. Farrell and co-workers [5,
6] provide no information regarding the food intake, but one has
to assume that the patients were non-fasting, since they were
studied repeatedly over several weeks. In these studies protein
catabolism during dialysis was evaluated by urea kinetic modeling
based on blood urea determinations. This method involves various
assumptions regarding urea distribution and equilibrium in the
body fluids and is therefore inaccurate.
It should be kept in mind that in the present study the period of
food deprivation preceding the experiments was no longer than 12
hours, and it cannot be excluded that glucose-free dialysis might
have had a more marked catabolic effect after starvation for a
longer period of time.
Since hemodialysis implies the rapid clearance of small mole-
cules (that is, urea, amino acids) primarily contained in the
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Fig. 1. Total amount of individual amino acids
in dialysate versus changes in leg release of amino
acids during hemodialysis using a dialysis fluid
with (A, GD; r = 0.93) or without glucose (B,
GFD; r = 0.90).
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Fig. 2. Plasma insulin levels (A) and plasma glucagon levels (B) in eight
hemodialysis patients, using a dialysis fluid with (, GD) or without glucose(, GFD); * P <0.05 compared to basal values.
extracellular compartment, adjacent compartments will continue
to release these molecules during the post-dialytic period. This
leads to a rapid rise in plasma concentrations (rebound) until a
new steady state is reached. Following hemodialysis similar in-
creases in the arterial concentrations of urea in the plasma
occurred in both groups, a finding that accords with a previously
reported rebound [31]. The present data do not permit any
conclusions to be drawn about whether this rebound also reflects
an accelerated urea generation rate due to dialysis-induced catab-
olism.
The results of the present study concerning changes in plasma
glucose, plasma insulin and loss of glucose into the dialysate or the
absorption of glucose from the dialysis fluid during hemodialysis
are in close agreement with other reports [13, 14, 32]. In accor-
dance with the results of a previous study [14], we found a highly
Fig. 4. Glucose absoiption/removal (g) in eight patients, using a dialysis
fluid with (GD) or without glucose (GFD).
.— significant correlation between the amount of glucose uptake or
loss during the dialysis and the respective changes in the glucose
and the insulin concentrations in the plasma.
GFD resulted in only a slight decrease in the plasma glucose
levels, which suggests that increased hepatic glucose production
must have made up for the loss of approximately 30 g glucose into
the dialysate. In normal fasting individuals, 60 to 75% of the
hepatic glucose release is derived from glycogenolysis and the rest
from gluconeogenesis [33]. It is likely that the improvement in
energy balance associated with the addition of glucose to the
dialysis fluid may reduce the metabolism of already impoverished
glucogenic substrates (mainly hepatic glycogen) in energy-corn-
promized patients.
In a previous study in healthy subjects we showed that the
contact between blood and regenerated cellulose membranes with
a high capacity for complement-activation, a sign of bioincompat-
ibility, led to a marked increase in muscle protein breakdown. On
the other hand, the use of more biocompatible, cellulose acetate
membranes was associated with only a slight, but insignificant
increase in leg efilux of amino acids [101. In the present study,
using dialysis membranes of identical (cellulose acetate) or com-
parable (Hemophan) biocompatibility properties, substantial in-
creases in amino acid efflux from the leg tissues were observed
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Fig. 3. Plasma glucose (mmol/liter) during and 60 minutes after hemodial-
ysis, using a dialysis fluid with (EJ, GD) or without glucose (•, GFD).
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Fig. 5. Plasma urea levels before, at the end of and during 60 minutes after
the end of hemodialysis treatment, using a dialysis fluid with (E, GD) or
without glucose (V, GFD).
Fig. 6. Amount of urea in dialysate after hemodialysis treatment, using a
dialysis fluid with (GD) or without glucose (GFD).
during the hemodialysis. Although blood-membrane interaction
and/or endotoxins in dialysis fluid may have contributed to the
enhanced muscle protein catabolism, our results suggest that the
loss of amino acids to the dialysate was the main factor causing the
marked increase in the release of amino acids in the leg.
In summary, as compared to dialysis with a fluid not containing
glucose, the addition of glucose to the dialysis fluid did not
improve nitrogen balance, although a positive energy balance was
obtained. In debilitated hemodialysis patients with deficient en-
ergy intake and exhausted glycogen stores, the use of a dialysis
fluid containing glucose may be of benefit. However, in view of the
practical disadvantages associated with the use of glucose-contain-
ing dialysis fluid (higher cost, increased bacterial and fungal
growth [34]) its routine use in clinical dialysis seems not to be
warranted.
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